{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:08:34Z","timestamp":1790737714980,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.semarthrit.2025.152832","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T17:55:40Z","timestamp":1758131740000},"page":"152832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Autonomic dysfunction symptoms in Sj\u00f6gren\u2019s Disease: A missed dimension linked to disease burden and work disability"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9895-7780","authenticated-orcid":false,"given":"Helena","family":"Achten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deroo","family":"Liselotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanhoof","family":"Sophie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De Boeck","family":"Kristel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deprez","family":"Joke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dumas","family":"Emilie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genbrugge","family":"Eva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bauters","family":"Wouter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roels","family":"Dimitri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dochy","family":"Frederick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Creytens","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elewaut","family":"Dirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4400-3655","authenticated-orcid":false,"given":"Peene","family":"Isabelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2025.152832_bib0001","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.semarthrit.2025.152832_bib0002","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3389\/fphys.2019.01104","article-title":"Autonomic abnormalities in patients with primary Sjogren's Syndrome - preliminary results","volume":"10","author":"Brunetta","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.semarthrit.2025.152832_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.702505","article-title":"Autonomic nervous system dysfunction in primary Sj\u00f6gren's Syndrome","volume":"12","author":"Davies","year":"2021","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152832_bib0004","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1136\/annrheumdis-2011-201009","article-title":"Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndrome","volume":"71","author":"Newton","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152832_bib0005","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/art.30282","article-title":"Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sj\u00f6gren's syndrome","volume":"63","author":"Park","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152832_bib0006","first-page":"2385","article-title":"Autonomic cardiovascular neuropathy in Sj\u00f6gren's syndrome. A controlled study","volume":"25","author":"Andonopoulos","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152832_bib0007","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/B978-0-12-804766-8.00008-X","article-title":"Autonomic dysfunction: diagnosis and management","volume":"167","author":"Rafanelli","year":"2019","journal-title":"Handb Clin Neurol"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152832_bib0008","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.mayocp.2012.10.013","article-title":"COMPASS 31: a refined and abbreviated composite autonomic symptom score","volume":"87","author":"Sletten","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152832_bib0009","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.autrev.2009.01.018","article-title":"Autonomic dysfunction in autoimmune rheumatic disease","volume":"8","author":"Stojanovich","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2025.152832_bib0010","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jim.2016.07.003","article-title":"Muscarinic type 3 receptor autoantibodies are associated with anti-SSA\/Ro autoantibodies in Sj\u00f6gren's syndrome","volume":"437","author":"Zuo","year":"2016","journal-title":"J Immunol Methods"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152832_bib0011","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/1529-0131(200007)43:7<1647::AID-ANR31>3.0.CO;2-P","article-title":"Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sj\u00f6gren's syndrome","volume":"43","author":"Waterman","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"9 Pt 2","key":"10.1016\/j.semarthrit.2025.152832_bib0012","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1016\/j.lpm.2012.05.019","article-title":"Pathogenic role of anti-M3 muscarinic acetylcholine receptor immune response in Sj\u00f6gren's syndrome","volume":"41","author":"Sumida","year":"2012","journal-title":"Presse Med"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152832_bib0013","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1093\/rheumatology\/keaa017","article-title":"Vaginal dryness in primary Sj\u00f6gren's syndrome: a histopathological case-control study","volume":"59","author":"van Nimwegen","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2025.152832_bib0014","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/00926230252851230","article-title":"Neurophysiology and pharmacology of female genital sexual response","volume":"28","author":"Giuliano","year":"2002","journal-title":"J Sex Marital Ther"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152832_bib0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11930-021-00305-8","article-title":"Local Genital Arousal: mechanisms for Vaginal Lubrication","volume":"13","author":"Dubinskaya","year":"2021","journal-title":"Curr Sex Health Rep"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152832_bib0016","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12576-015-0399-y","article-title":"Frontier studies on fatigue, autonomic nerve dysfunction, and sleep-rhythm disorder","volume":"65","author":"Tanaka","year":"2015","journal-title":"J Physiol Sci"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152832_bib0017","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American college of rheumatology\/european league against rheumatism classification criteria for primary Sj\u00f6gren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152832_bib0018","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/rheumatology\/keh588","article-title":"Ultrasonographic changes of major salivary glands in primary Sjogren's syndrome. Diagnostic value of a novel scoring system","volume":"44","author":"Hocevar","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152832_bib0019","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/annrheumdis-2019-215024","article-title":"Video clip assessment of a salivary gland ultrasound scoring system in Sj\u00f6gren's syndrome using consensual definitions: an OMERACT ultrasound working group reliability exercise","volume":"78","author":"Jousse-Joulin","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152832_bib0020","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ajo.2009.09.013","article-title":"A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sj\u00f6gren's syndrome international registry","volume":"149","author":"Whitcher","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152832_bib0021","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American college of rheumatology\/european league against rheumatism classification criteria for primary Sj\u00f6gren's syndrome","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152832_bib0022","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/ard.2010.143743","article-title":"EULAR Sjogren's Syndrome patient reported index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome","volume":"70","author":"Seror","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152832_bib0023","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/S2665-9913(19)30042-6","article-title":"Symptom-based stratification of patients with primary Sj\u00f6gren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials","volume":"1","author":"Tarn","year":"2019","journal-title":"Lancet Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152832_bib0024","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2025.152832_bib0025","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/clinids\/18.Supplement_1.S79","article-title":"Measuring the functional impact of fatigue: initial validation of the fatigue impact scale","volume":"18","author":"Fisk","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152832_bib0026","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.pmrj.2015.08.008","article-title":"Patients with fibromyalgia have significant autonomic symptoms but modest autonomic dysfunction","volume":"8","author":"Vincent","year":"2016","journal-title":"Pm R"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152832_bib0027","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/rheumatology\/keu522","article-title":"The impact of primary Sj\u00f6gren's syndrome on female sexual function","volume":"54","author":"van Nimwegen","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152832_bib0028","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.rbr.2016.05.009","article-title":"Are the women with Sj\u00f6gren's Syndrome satisfied with their sexual activity?","volume":"57","author":"Isik","year":"2017","journal-title":"Rev Bras Reumatol Engl editor"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152832_bib0029","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2014-000022","article-title":"EULAR Sj\u00f6gren's syndrome disease activity index (ESSDAI): a user guide","volume":"1","author":"Seror","year":"2015","journal-title":"RMD Open"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152832_bib0030","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1016\/S2665-9913(21)00122-3","article-title":"Composite of Relevant Endpoints for Sj\u00f6gren's Syndrome (CRESS): development and validation of a novel outcome measure","volume":"3","author":"Arends","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152832_bib0031","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1136\/annrheumdis-2021-222054","article-title":"Development and preliminary validation of the Sj\u00f6gren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sj\u00f6gren's syndrome","volume":"81","author":"Seror","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152832_bib0032","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ard-2023-224503","article-title":"Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome: proteomic and network analysis","volume":"83","author":"Berry","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152832_bib0033","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39629","article-title":"Association of increased treg cell levels with elevated indoleamine 2,3-dioxygenase activity and an imbalanced kynurenine pathway in interferon-positive primary Sj\u00f6gren's Syndrome","volume":"68","author":"Maria","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152832_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21062194","article-title":"Role of interleukin-6 in depressive disorder","volume":"21","author":"Ting","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152832_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030123","article-title":"Interleukin-1 inhibition and fatigue in primary Sj\u00f6gren's syndrome\u2013a double blind, randomised clinical trial","volume":"7","author":"Norheim","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152832_bib0036","first-page":"85","article-title":"Interleukin-6 blockade improves autonomic dysfunction in rheumatoid arthritis","volume":"40","author":"Syngle","year":"2015","journal-title":"Acta Reumatol Port"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152832_bib0037","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI30555","article-title":"Physiology and immunology of the cholinergic antiinflammatory pathway","volume":"117","author":"Tracey","year":"2007","journal-title":"J Clin Invest"},{"issue":"5\u20138","key":"10.1016\/j.semarthrit.2025.152832_bib0038","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF03402177","article-title":"The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation","volume":"9","author":"Pavlov","year":"2003","journal-title":"Mol Med"},{"key":"10.1016\/j.semarthrit.2025.152832_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104622","article-title":"The cholinergic anti-inflammatory pathway in humans: state-of-the-art review and future directions","volume":"136","author":"Alen","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.semarthrit.2025.152832_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120171","article-title":"Vagus nerve stimulation: an update on a novel treatment for treatment-resistant depression","volume":"434","author":"Kamel","year":"2022","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152832_bib0041","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neurom.2022.08.461","article-title":"The effects of noninvasive vagus nerve stimulation on fatigue in participants with primary Sj\u00f6gren's Syndrome","volume":"26","author":"Tarn","year":"2023","journal-title":"Neuromodulation"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152832_bib0042","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s42234-023-00138-x","article-title":"Clinical safety and feasibility of a novel implantable neuroimmune modulation device for the treatment of rheumatoid arthritis: initial results from the randomized, double-blind, sham-controlled RESET-RA study","volume":"10","author":"Peterson","year":"2024","journal-title":"Bioelectron Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152832_bib0043","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3899\/jrheum.160932","article-title":"Work disability in newly diagnosed patients with primary Sj\u00f6gren Syndrome","volume":"44","author":"Mandl","year":"2017","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152832_bib0044","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1080\/1744666X.2023.2234641","article-title":"Why do drug treatments fail in Sj\u00f6gren's disease? Considerations for treatment, trial design and interpretation of clinical efficacy","volume":"19","author":"Arends","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152832_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2021.101735","article-title":"Treating-to-target in rheumatology: theory and practice","volume":"36","author":"Duarte","year":"2022","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152832_bib0046","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0196-9781(87)90061-1","article-title":"Vasoactive intestinal polypeptide (VIP) provokes vaginal lubrication in normal women","volume":"8","author":"Ottesen","year":"1987","journal-title":"Peptides"},{"issue":"Suppl 3","key":"10.1016\/j.semarthrit.2025.152832_bib0047","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1743-6109.2008.01122.x","article-title":"Endothelial nitric oxide synthase regulation in female genital tract structures","volume":"6","author":"Musicki","year":"2009","journal-title":"J Sex Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152832_bib0048","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/odi.12249","article-title":"Effect of the neuropeptides vasoactive intestinal peptide, peptide histidine methionine and substance P on human major salivary gland secretion","volume":"21","author":"Del Fiacco","year":"2015","journal-title":"Oral Dis"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152832_bib0049","first-page":"287","article-title":"Distribution of vasoactive intestinal peptide (VIP) and its binding sites in labial salivary glands in Sj\u00f6gren's syndrome and in normal controls","volume":"12","author":"T\u00f6rnwall","year":"1994","journal-title":"Clin Exp Rheumatol"},{"issue":"29","key":"10.1016\/j.semarthrit.2025.152832_bib0050","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.2174\/1381612820666140130203636","article-title":"Neuroimmune aspects of Sjogren's syndrome: role of VIP\/VPAC system in immune and salivary gland epithelial cell function","volume":"20","author":"Vanesa","year":"2014","journal-title":"Curr Pharm Des"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152832_bib0051","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00296-021-04927-y","article-title":"Revisiting the JOQUER trial: stratification of primary Sj\u00f6gren's syndrome and the clinical and interferon response to hydroxychloroquine","volume":"41","author":"Collins","year":"2021","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2025.152832_bib0052","series-title":"Report of the 4th international symposium. Autoimmun Rev","article-title":"Autoantibodies targeting G protein-coupled receptors: an evolving history in autoimmunity","volume":"22","author":"Cabral-Marques","year":"2023"}],"updated-by":[{"DOI":"10.1016\/j.semarthrit.2025.152860","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000}}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225002033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225002033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:55:28Z","timestamp":1765979728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017225002033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":52,"alternative-id":["S0049017225002033"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152832","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autonomic dysfunction symptoms in Sj\u00f6gren\u2019s Disease: A missed dimension linked to disease burden and work disability","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152832","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152832"}}